Bradykinesia in early Huntington's disease

Area of Science:

• Neuroscience
• Neurology
• Radiochemistry

Background:

• Huntington's disease (HD) is often viewed as hyperkinetic, but hypokinetic features are present.
• The striatum is crucial for motor control and response generation.
• Previous studies on HD clinical features and progression markers have yielded conflicting results.

Purpose of the Study:

• To investigate the relationship between motor and cognitive deficits in early HD.
• To assess neuronal loss in the striatum using raclopride C11 and Positron Emission Tomography (PET).

Main Methods:

• Cross-sectional study of 11 patients with mild HD (stages 0-2).
• Assessed motor function using the Unified Huntington's Disease Rating Scale (UHDRS) and other measures.
• Evaluated cognitive function using various tests including verbal fluency and memory assessments.
• Correlated clinical scores with striatal raclopride C11 binding measured by PET.

Main Results:

• Bradykinesia strongly predicted HD stage and correlated with putamen D2 binding (r = -0.94).
• CAG repeat expansion length x age also correlated with disease stage (r = 0.96).
• Cognitive test performance, particularly timed tasks, correlated with D2 binding in the caudate nucleus and ventral striatum.

Conclusions:

• Striatal D2 binding loss is significantly associated with deficits in rapid motor and cognitive processing in early HD.
• Impaired ability to quickly respond to environmental changes is a common manifestation of striatal dysfunction in HD.
• Findings highlight the importance of assessing both motor and cognitive processing speed in early HD management.